SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-18-009568
Filing Date
2018-04-27
Accepted
2018-04-27 16:00:54
Documents
6
Period of Report
2018-06-18
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A sbph-def14a_20180618.htm DEF 14A 833482
2 GRAPHIC g2018042715490175620698.jpg GRAPHIC 5838
3 GRAPHIC g2018042715490225920700.jpg GRAPHIC 1565
4 GRAPHIC g2018042715490176620699.jpg GRAPHIC 1565
5 GRAPHIC g2018042715491001220701.jpg GRAPHIC 67534
6 GRAPHIC g2018042715491004820702.jpg GRAPHIC 83267
  Complete submission text file 0001564590-18-009568.txt   1055268
Mailing Address 86 SOUTH STREET HOPKINTON MA 01748
Business Address 86 SOUTH STREET HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37718 | Film No.: 18783725
SIC: 2834 Pharmaceutical Preparations